Three Ways to Address Clinical Burnout and Health Care Drug Diversion
As any health care leader can attest, the
stress of COVID-19, clinical staffing shortages, and burnout have taken a
measurable toll on hospitals, impacting operations and patients in unforeseen
ways, from elective-surgery scheduling postponements to prolonged emergency
department wait times.
Ratios of clinicians to patients are
becoming even more strained.
Retirements, staff layoffs stemming from
vaccine mandates, plus cuts in staffing due to workers testing positive, have
led to a rush to hire temporary nurses and other clinicians to handle the
current surge in hospitalizations. As of January 9, nearly 137,000 people were
reportedly hospitalized with COVID-19 in the United States—more than 5 times as
many as were in early July. cloud-based drug diversion software can detect and
prevent the diversion of opioids and other prescription drugs.
But although staffing challenges mean health care leaders may have to shift priorities, one area where they shouldn’t scale back is in their efforts to stop health care drug diversion. If anything, our efforts to fight diversion should double.
Since the onset of the COVID-19 pandemic, a
surge in patient volumes and emotionally draining shifts are blamed more
frequently for triggering anxiety and other mental health issues, which is
correlated with substance abuse and substance user disorder (SUD). Given that
addictive substances are easier to obtain in health care settings also raises
the risk of diversion.
The
implications for organizations are steep: Drug
diversion costs the health care industry upwards of $70 billion per year and is
linked with the spread of health care acquired infections (HAI) among patients.
Between 2005 and 2015, the United States recorded more than twice as many HAI
outbreaks (e.g., hepatitis C) than between 1985 and 2005.
More than 8 in 10 health care professionals
(82%) know or have met someone who has diverted drugs, according to a 2021
report based by Invistics and Porter Research.
Sadly, instead of prioritizing drug
diversion, these conditions are causing many organizations to have fewer
resources and controls to prevent diversion. Forty-seven percent of respondents
to the most recent Invistics/Porter Research drug-diversion survey revealed
staff turnover due to the coronavirus has made it more challenging to track
drug diversion, while 38% said resources for investigations were reallocated
due to budget concerns.
Health care organizations reported slightly
less staff dedicated to their drug diversion program and investigations, with
45% saying they employed one or more full-time professionals, down from 58% who
said the same in 2019.
The health care staff who might be tempted
to divert for personal use—or put in a position of reporting their
colleagues—deserve better.
The Ripple
Effect of the Health Care Staffing Crisis and Burnout
Even before March 2020, health care worker
shortages affected organizations. In 2019, the Association of American Medical
Colleges, which publishes an annual report on shortages, projected a shortfall
of 40,000 to 122,000 physicians —which it revised in June 2021 due to the
impact of the coronavirus pandemic. The revised projections appear to be worse
than the earlier ones.
Moving into 2022, health care organizations
are being pressured from all directions. Hopes of returning to normalcy have
eroded recently, while the “Great Resignation” has led to many clinicians
rethinking their line of work and voluntarily quitting medicine.
All of these factors have spurred huge wage
increases for clinicians and a rise in temporary staffing at health facilities.
This is especially concerning because it could raise the risk of diversion if
workers aren’t appropriately vetted with thorough background checks.
Among the clinicians who are staying put,
burnout is rampant. As many as 4 in 5 respondents to the third annual Medical
Economics Physician Wellness and Burnout survey said they currently feel burned
out. And as Peter Grinspoon, MD, author of the memoir Free Refills: A Doctor
Confronts His Addiction, noted in a recent blog, burnout “manifests in
disproportionately high rates of depression, substance abuse, and suicide.”
These are important things to consider,
given that, in 2020, US drug overdose deaths rose by nearly 30% to a record
93,331 national deaths. As we have seen time and again from trends data, what’s
happening outside of hospitals reflects what’s happening within them, with dire
outcomes for the workers we rely on and love.
In November, the University of Texas
Southwestern Medical Center agreed to pay a $4.5 million civil settlement for
violations of the Controlled Substances Act that allowed hospital staff to
divert fentanyl and other drugs, incidents that ultimately caused the overdose
deaths of two nurses on staff.
A New Frontier in Drug Diversion,
Prevention and Help in Detection
Understandably, available resources to
address diversion, given these broader challenges, are clearly constrained. Not
every health system has the budget to employ enough dedicated drug diversion program with professionals.
But there are a few smart investments and small changes that can significantly
reduce hospital systems’ risk of health care diversion and its most dire
consequences. For 2022, health leaders should focus on enhancing the following
areas:
1. Training
and education
New staff training and orientation programs
offer an important opportunity to educate incoming workers about everything
from safety protocols and compliance to handling the stress of treating COVID
patients. And while most staff training includes basic education around drug
diversion, health care leaders should ensure they’re emphasizing the
consequences of diversion (the potential injuries to patients and colleagues
being foremost). Leadership should also ensure help and treatment is available
to any staff experiencing SUD. Workers should be encouraged to discuss their
own feelings of burnout. There is no shame in asking for help.
2. Internal
reporting
Abating diversion starts with awareness and
transparency. Clinical supervisors should stress that the potential patient
harm and legal ramifications connected to diversion impact, everyone. Education
needs to address the pervasive “don’t ask, don’t tell” culture. Many clinicians
are afraid that telling on another worker would affect their colleague’s
livelihood, when in fact it might be the best approach for getting that person
the help they need, as well as protecting patients.
Training can also include suggestions about submitting anonymous tips to HealthcareDiversion.org.
3.
Technology
A growing number of health care
professionals are investing in advanced technology systems to track medication
within the supply chain, and to detect when those medications are diverted.
While nearly 9 in 10 health care leaders (86%) say their organization uses
automated dispensing cabinets, and many use security cameras or auditing
solutions, these standalone technologies aren’t sufficient in detecting the
patterns and behaviors associated with diversion.
What health care organizations need is
solutions that enable them to consolidate data from multiple IT
systems—electronic medical records, practice management systems,
medication-dispensing cabinets, employee time clocks, and wholesaler purchasing
records. Machine learning technologies and software can pick up on indicators,
or patterns, associated with drug diversion.
The more data this software processes, the
better its accuracy in identifying (flagging) the actual behaviors and patterns
associated with diversion, e.g., a combination of inconsistent pain-scale
scores when comparing multiple clinicians caring for the same patients.
With fewer hands available to take an “all hands-on deck” approach at hospitals and health centers, health care leaders need to seek out new ways to prevent diversion. Enhancing education, reporting, and technology tools can go a long way in helping health systems strengthen their defenses against drug diversion detection, so they can continue to focus on what’s most important: Providing care to patients.

Comments
Post a Comment